Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
VTGN similar filings
- 25 Apr 24 Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
- 1 Apr 24 Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder following Positive Results of PALISADE-2
- 13 Feb 24 Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
- 8 Jan 24 Regulation FD Disclosure
- 3 Jan 24 Vistagen Receives Notice from European Patent Office of Intention to Grant Patent for AV-101 to Treat Neuropathic Pain
- 9 Nov 23 Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results
- 6 Nov 23 Other Events
Filing view
External links